Yale School of Medicine Introduces the Yale Biomedical Imaging Institute
On June 21, 2025, the
Yale School of Medicine (YSM) made a significant stride in medical research with the inauguration of the
Yale Biomedical Imaging Institute (YBII). This state-of-the-art institution is set to serve as an interdisciplinary hub, uniting leading experts in imaging technology, clinical translation, and data science to push the boundaries of biomedical imaging and improve human health.
Georges El Fakhri, PhD, who is the inaugural director of the institute, expressed his enthusiasm about the establishment of this center. He stated, "The Yale Biomedical Imaging Institute brings together world-class talent and resources to accelerate discovery and impact in medicine." His team comprises prominent figures such as Chi Liu, PhD, and Dustin Scheinost, PhD, both of whom will act as associate directors of biomedical imaging technologies. Additionally, Xenophon Papademetris, PhD, has been appointed as the associate director for imaging data sciences, while Kelly Cosgrove, PhD, will lead the translational imaging efforts.
The creation of the Yale Biomedical Imaging Institute stems from a year-long strategic planning initiative led by
Dean Nancy J. Brown, MD, alongside El Fakhri, Liu, and Douglas Rothman, PhD. The institute's concept was shaped through more than 40 discussion sessions within Yale's scientific and engineering communities, revealing a strong desire for a coordinated approach to biomedical imaging.
Goals of the Institute
The primary objectives of the YBII include:
- - Developing cutting-edge technologies for various modalities in biomedical imaging.
- - Translating findings to guide diagnostics and treatment decisions.
- - Utilizing artificial intelligence and data science to enhance clinical research and care delivery.
Moreover, the institute will integrate the existing capabilities of Yale's long-established centers and cores, such as the
Positron Emission Tomography (PET) center and the
Magnetic Resonance Imaging (MRI) research center, blending these with advanced imaging data science expertise. Initial initiatives will include postdoctoral training opportunities and funding avenues for exploratory research.
In his remarks, Brian Smith, MD, the vice dean for clinical and translational research, noted the unique opportunity at Yale to create a world-class imaging institute built upon the strength of its current programs. The YBII aims to bolster research in brain imaging, oncology, cardiovascular imaging, and inflammation diagnostics, while also expanding initiatives in early disease detection.
A crucial aspect of the YBII’s mission is centered around data science, employing deep learning techniques to process and curate extensive image datasets. This approach promises to benefit both Yale researchers and the broader research community.
Douglas Rothman emphasized the historical leadership Yale has achieved in the realm of imaging, stating, "This institute solidifies Yale's longstanding commitment to staying at the forefront of translational and clinical research."
About Yale School of Medicine
Yale School of Medicine is a prestigious institution renowned for educating leaders in medicine and science. The school prioritizes curiosity, critical thinking, and independent research, standing at the forefront of biomedical research, clinical care, and medical education. With over 1,700 physicians, Yale provides compassionate healthcare services to patients globally.
The establishment of the Yale Biomedical Imaging Institute marks a pivotal moment in medical research, promising innovative advancements that can significantly improve health outcomes and treatment options in the future.